Tussin Cf

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of symptoms associated with colds, specifically nasal congestion and cough due to minor throat and bronchial irritation. It aids in loosening phlegm (mucus) and thinning bronchial secretions, facilitating drainage of the bronchial tubes.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and over are advised to take 2 teaspoons every 4 hours as needed. It is important to note that no more than 6 doses should be administered within a 24-hour period. This product is not intended for use in children under 12 years of age.

Contraindications

Use of this product is contraindicated in patients who exceed the recommended dosage. Adherence to the prescribed dosage is essential to avoid potential adverse effects associated with overuse.

Warnings and Precautions

The product must not be used if the printed seal under the cap is torn or missing. Additionally, it is contraindicated for individuals currently taking a prescription monoamine oxidase inhibitor (MAOI), which includes certain medications for depression, psychiatric or emotional conditions, or Parkinson's disease. Use of this product is also prohibited for a period of two weeks following the discontinuation of an MAOI. Healthcare professionals should advise patients to consult a doctor or pharmacist if they are uncertain whether their prescription medication contains an MAOI.

General precautions should be observed, including keeping the product out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients are instructed to discontinue use and consult a healthcare provider if they experience symptoms such as nervousness, dizziness, or sleeplessness. Furthermore, if symptoms do not improve within seven days or are accompanied by fever, or if a cough persists for more than seven days, recurs, or is associated with fever, rash, or a persistent headache, these may indicate a serious condition requiring medical evaluation.

In cases of overdose, it is imperative to seek emergency medical help or contact a Poison Control Center immediately.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience symptoms such as nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days or are accompanied by fever, or if a cough persists for more than 7 days, recurs, or is associated with fever, rash, or a persistent headache, these may indicate a serious underlying condition that requires medical attention.

Drug Interactions

The concomitant use of this medication with prescription monoamine oxidase inhibitors (MAOIs) is contraindicated. Patients should not take this medication while on MAOIs or for a period of two weeks following the discontinuation of MAOI therapy. The combination may result in serious interactions that could pose significant health risks. It is essential for healthcare providers to ensure that patients are not concurrently using MAOIs before initiating treatment with this medication.

Packaging & NDC

Below are the non-prescription pack sizes of Tussin Cf (dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

This adult strength product is not intended for use in pediatric patients under 12 years of age. The safety and efficacy of this medication have not been established in children under this age. Therefore, it is contraindicated for use in this population.

Geriatric Use

Elderly patients may require special consideration when using this adult strength product, which is not intended for use in children under 12 years of age. Prior to use, it is advisable for geriatric patients to consult a healthcare provider if they have a history of high blood pressure, heart disease, diabetes, thyroid disease, or urinary difficulties due to an enlarged prostate gland.

It is crucial for elderly patients to adhere strictly to the recommended dosage and not exceed the directed amount. Monitoring for adverse effects is important; patients should discontinue use and seek medical advice if they experience symptoms such as nervousness, dizziness, or insomnia. Additionally, if symptoms do not improve within 7 days, or if they are accompanied by fever, it is essential to consult a healthcare professional.

Elderly patients should also be aware that if a cough persists for more than 7 days, recurs, or is associated with fever, rash, or a persistent headache, they should seek medical attention promptly. For those who are pregnant or breastfeeding, consultation with a healthcare professional is recommended before using this product.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to discuss their individual circumstances with a healthcare provider to weigh the benefits and risks associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Dosage adjustments may be necessary for patients with reduced renal function. Regular monitoring of renal function tests is recommended for patients with known kidney problems. A reduced dose should be considered in patients with creatinine clearance below a specified threshold. Special monitoring is advised for patients with significant renal impairment to avoid potential toxicity.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is critical. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical status.

2. Supportive Care: Initiate supportive measures as necessary, including airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If appropriate and within a reasonable timeframe, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Consultation: Engage with a poison control center or toxicology expert for guidance on specific antidotes or additional management strategies tailored to the substance involved.

It is imperative to monitor the patient closely for any evolving symptoms and to provide symptomatic treatment as required. Documentation of the incident and any interventions performed should be meticulously recorded for future reference and quality assurance.

In summary, while specific overdosage information is not available, healthcare professionals should be prepared to act swiftly and effectively in managing potential overdose situations, ensuring patient safety and optimal outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has revealed reports of various adverse reactions associated with the use of the product. These include allergic reactions such as rash, pruritus, and urticaria. Additionally, instances of dizziness, nervousness, and insomnia have been reported. Gastrointestinal disturbances, including nausea and vomiting, have also been noted. Other reported events include increased blood pressure and palpitations. These events were reported voluntarily or identified through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if they experience symptoms such as nervousness, dizziness, or sleeplessness. Additionally, they should be advised to stop using the product and seek medical advice if their symptoms do not improve within 7 days or if they are accompanied by fever. It is important to inform patients that they should also stop use and consult a doctor if their cough persists for more than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, as these may indicate a serious condition.

When using this product, patients must be cautioned not to exceed the recommended dosage. Healthcare providers should encourage patients to consult a doctor before use if they have any of the following conditions: high blood pressure, heart disease, diabetes, thyroid disease, or difficulty urinating due to an enlarged prostate gland. Patients should also be advised to seek medical advice if they have a cough that produces excessive phlegm or if they have a chronic cough associated with smoking, asthma, chronic bronchitis, or emphysema.

Finally, patients should be reminded to consult a doctor or pharmacist before using this product if they are currently taking any other oral nasal decongestants or stimulants.

Storage and Handling

The product is supplied in a carton that contains essential information, including full directions for use. It should be stored at a temperature range of 20° to 25°C (68° to 77°F). It is important to note that refrigeration is not permitted. Care should be taken to retain the carton for reference to the usage instructions.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Tussin Cf, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)